Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ultrasound vs. antibiotics: a new way to treat kids with pneumonia?

NCT ID NCT06921993

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether using lung ultrasound can help doctors avoid giving antibiotics to children who don't need them. About 659 children aged 3 to 10 with suspected pneumonia will be randomly assigned to get either standard care or care guided by lung ultrasound. The goal is to see if the ultrasound approach leads to fewer antibiotic prescriptions without harming recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 659 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 10 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Well-appearing, clinically stable patients aged 3 to 10 years, presenting to the pediatric ED with suspected pneumonia based on a combination of signs and symptoms suggestive of lower respiratory tract infection (LRTI), including: 1. Respiratory Symptoms: Cough, Tachypnea, Dyspnea (Increased work of breathing), Abnormal findings on auscultation. 2. Systemic Symptoms: Fever, Hypoxia, Decreased appetite. Exclusion Criteria: * Neonates and children up to 3 years of age, and children older than 10 years * Children aged 3 to 10 years with any of the following factors: 1. Recent hospitalization (within the past 14 days) 2. Prior CXR or any other chest imaging (e.g. CT scan) 3. Ongoing antibiotic therapy 4. Hemodynamic instability 5. Respiratory failure or severe respiratory distress and/or hypoxemia, requiring urgent assessment for conditions such as pneumothorax, hemothorax, or other emergency respiratory conditions 6. History of aspiration or ab ingestis pneumonia 7. Underlying medical conditions predisposing to severe or recurrent pneumonia, including immunodeficiency, chronic corticosteroid use, chronic lung disease, malignancy, sickle cell disease, congenital heart disease, tracheostomy, and neuromuscular disorders affecting respiration

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Antibiotic stewardship are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    14 sites in 3 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • ASST Papa Giovanni XXIII

    RECRUITING

    Bergamo, Italy

  • Azienda Ospedale Università di Padova

    RECRUITING

    Padova, Italy

  • Columbia University

    NOT_YET_RECRUITING

    New York, New York, 10027, United States

  • IRCCS Fondazione Cà Granda - Policlinico

    ACTIVE_NOT_RECRUITING

    Milan, Italy

  • IRCCS Gemelli

    ACTIVE_NOT_RECRUITING

    Roma, Italy

  • IRCCS Istituto Giannina Gaslini

    RECRUITING

    Genova, Italy

  • IRCCS Sant'Orsola

    RECRUITING

    Bologna, Italy

  • Meyer Children's Hospital IRCCS

    RECRUITING

    Florence, Italy, 50139, Italy

    Contact Email: •••••@•••••

  • Ospedale Burlo Garofolo

    NOT_YET_RECRUITING

    Trieste, Italy

  • Ospedale Infantile Regina Margherita

    NOT_YET_RECRUITING

    Torino, Italy

  • Ospedale Maggiore della Carità

    RECRUITING

    Novara, Italy

  • Ospedale Pediatrico Bambino Gesù

    NOT_YET_RECRUITING

    Roma, Italy

  • Ospedale Pediatrico Santobono - Pausillipon

    NOT_YET_RECRUITING

    Naples, Italy

  • Ospedale dei Bambini

    NOT_YET_RECRUITING

    Brescia, Italy

  • Rady Childrens/UCSD

    ACTIVE_NOT_RECRUITING

    San Diego, California, 92123, United States

  • Schneider Children's Hospital

    NOT_YET_RECRUITING

    Petah Tikva, 49202, Israel

  • University of Wisconsin

    ACTIVE_NOT_RECRUITING

    Madison, Wisconsin, 53706, United States

  • Yale New Haven Children's Hospital

    RECRUITING

    New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.